Pediatr. pro Praxi, 2006; 2: 80-90 [Klin Farmakol Farm. 2006;20(2):75-82]

Allergic rhinitis

doc. MUDr. František Kopřiva Ph.D
Dětská klinika LF UP a FN Olomouc

The prevalence of allergic rhinitis has been increasing in the last decade, particularly in the paediatric population. The current classification is based on assessment of the severity and duration of the complaints and their influence on the patient‘s quality of life. Nasal symptoms in allergic rhinitis are due to the action of a wide range of mediators on various receptors. Itching and sneezing are caused by irritation of the sensory nerve endings, hypersecretion is induced reflexly by activation of the parasympathetic cholinergic fibres. Mucosal swelling is due to increased vascular permeability and mainly due to increased filling of the capillaries and capacity vessels in the nasal mucosa following H1 or, less frequently, H2 receptor interference.

Keywords: allergic rhinitis, aetiopathogenesis, diagnosis, treatment, bronchial asthma

Published: June 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kopřiva F. Allergic rhinitis. Pediatr. praxi. 2006;7(2):80-90.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alergická rýma a její vliv na astma. Kapesní průvodce pro lékaře a zdravotní sestry. ČIPA 2002 Jalna Praha.
    2. Berge WE. The safety and efficacy of desloratadine for the management of allergic disease. Drug Saf. 2005; 28 (12), 101-18. Go to original source...
    3. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assesment of quality of life in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1994, 94, 182-188. Go to original source... Go to PubMed...
    4. van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, Fokkens WJ, Howarth PH, Lund V, Malling HJ, Mygind N, Passali D, Scadding GK, Wang DY. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergollogy and Clinical Immunology. Allergy 2000, 55(2), 116-34. Go to original source... Go to PubMed...
    5. Dahl R. Rhinitis and asthma. In: Mygind A, Nacleiro R, Eds. Allergic and non allergic rhinitis, Copenhagen, Munksgaard,1993, 184-188.
    6. Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Mudroch RD, Durham SR Barnes PJ, Hansel TT. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following alergen challenge. Clin Exp Allergy. 2005; 35(12), 1608-14. Go to original source... Go to PubMed...
    7. Frieri M. Inflammatory issues in allergic rhinitis and asthma. Allergy Asthma Proc. 2005; 26(3), 163-9. Go to PubMed...
    8. Howarth PH, Holmberg K. Allergic rhinitis: an increasing clinical problem. Allergy 1995, 50, 4-5. Go to original source... Go to PubMed...
    9. Lange B, Lukat KF, Holtappels G, Bachert C. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2005; 95(3), 272-82. Go to original source... Go to PubMed...
    10. Meltzer EO. Pediatric issues in ARIA, ARIA symposium,58th AAAAI Annual Meeting, New York, March 2 2002.
    11. Rybníček O. Moderní přístup k diagnostice a léčbě pylové alergie. [The modern approach to diagnosis and treatment of pollen allergy] Cas Lek Cesk. 1998, 137(13), 391-6. Go to PubMed...
    12. Rybníček O, Jäger S. Ambrosia (Ragweed) in Europe. Allergy Clin Immunol International 2001; 13(2), 60-66. Go to original source...
    13. Rybníček O. Pylová alergie. Remedia 2004; 1(14), 56-68.
    14. Rybníček O, Seberová E. (eds.) et al. Průvodce specifickou alergenovou imunoterapií (Doporučení výboru ČSAKI). Tigis, Praha, květen 2004, 48.
    15. Seberová E. ARIA - alergická rýma a její vliv na astma. Alergie, 2002, 4, Suppl 2, 6-8.
    16. Seberová E. Chronická rýma in Alergologie, Galén, 2004, 175.
    17. Sublett JL. The environment and risk factors for atopy. Curr Allergy Asthma Rep. 2005; 5(6), 445-50. Go to original source... Go to PubMed...
    18. Wheeler PW, Wheeler SF. Vasomotor rhinitis. Am Fam Physician. 2005 15; 72(6), 1057-62. Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.